Literature DB >> 7316981

Evidence for an essential arginine residue at the active site of ATP citrate lyase from rat liver.

S Ramakrishna, W B Benjamin.   

Abstract

Rat liver ATP citrate lyase was inactivated by 2, 3-butanedione and phenylglyoxal. Phenylglyoxal caused the most rapid and complete inactivation of enzyme activity in 4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid buffer, pH 8. Inactivation by both butanedione and phenylglyoxal was concentration-dependent and followed pseudo- first-order kinetics. Phenylglyoxal also decreased autophosphorylation (catalytic phosphate) of ATP citrate lyase. Inactivation by phenylglyoxal and butanedione was due to the modification of enzyme arginine residues: the modified enzyme failed to bind to CoA-agarose. The V declined as a function of inactivation, but the Km values were unaltered. The substrates, CoASH and CoASH plus citrate, protected the enzyme significantly against inactivation, but ATP provided little protection. Inactivation with excess reagent modified about eight arginine residues per monomer of enzyme. Citrate, CoASH and ATP protected two to three arginine residues from modification by phenylglyoxal. Analysis of the data by statistical methods suggested that the inactivation was due to modification of one essential arginine residue per monomer of lyase, which was modified 1.5 times more rapidly than were the other arginine residues. Our results suggest that this essential arginine residue is at the CoASH binding site.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7316981      PMCID: PMC1162946          DOI: 10.1042/bj1950735

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Essential arginyl residues in Escherichia coli alkaline phosphatase.

Authors:  F J Daemen; J F Riordan
Journal:  Biochemistry       Date:  1974-07-02       Impact factor: 3.162

2.  The number of catalytically essential carboxyl groups in pepsin. Modification of the enzyme by trimethyloxonium fluoroborate.

Authors:  A K Paterson; J R Knowles
Journal:  Eur J Biochem       Date:  1972-12-18

Review 3.  The citrate enzymes: their structures, mechanisms, and biological functions.

Authors:  P A Srere
Journal:  Curr Top Cell Regul       Date:  1972

4.  Functional arginyl residues in carboxypeptidase A. Modification with butanedione.

Authors:  J F Riordan
Journal:  Biochemistry       Date:  1973-09-25       Impact factor: 3.162

5.  Studies on ATP citrate lyase of rat liver. V. The binding site of phosphate.

Authors:  F Suzuki; K Fukunishi; Y Takeda
Journal:  J Biochem       Date:  1969-12       Impact factor: 3.387

6.  Nature of the phosphorylated residue in citrate clevage enzyme.

Authors:  G L Cottam; P A Srere
Journal:  Biochem Biophys Res Commun       Date:  1969-06-27       Impact factor: 3.575

7.  Citryl phosphate and the mode of action of the citrate cleavage enzyme.

Authors:  C T Walsh; L B Spector
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

8.  A simple method for the preparation of 32-P-labelled adenosine triphosphate of high specific activity.

Authors:  I M Glynn; J B Chappell
Journal:  Biochem J       Date:  1964-01       Impact factor: 3.857

9.  Chemical modification of the arginines in transferrins.

Authors:  T B Rogers; T Børresen; R E Feeney
Journal:  Biochemistry       Date:  1978-03-21       Impact factor: 3.162

10.  Studies on adenosine triphosphate citrate lyase of rat liver. Binding site of citrate.

Authors:  F Suzuki
Journal:  Biochemistry       Date:  1971-07-06       Impact factor: 3.162

View more
  2 in total

1.  Effect of ligands on chemical modification of proteins.

Authors:  K Horiike; H Tojo; T Yamano; M Nozaki
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

2.  Arginine is essential for the alpha-amylase inhibitory activity of the alpha-amylase/subtilisin inhibitor (BASI) from barley seeds.

Authors:  J Abe; U Sidenius; B Svensson
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.